CLOSE

Trials of hydroxychloroquine in the treatment of corona will resume: WHO


Switzerland, Ta. 4 June 2020, Thursday

The World Health Organization (WHO) has decided to reintroduce the hydroxychloroquine drug used in the treatment of malaria as a trial in the treatment of corona. The trial of hydroxychloroquine will be resumed on Wednesday, World Health Organization President Tedros Adnom Gabreyes said.

Earlier, the World Health Organization (WHO) had stopped the trial of hydroxychloroquine, saying it was harmful to health. During a virtual news briefing, Tedros said, "Given the available death toll, the executive group will inform principal investigators about resuming trials of hydroxychloroquine."

The trial of the drug was halted last week due to security concerns. A report said there was no evidence that hydroxychloroquine was beneficial and that the health organization had since banned it.

This drug called hydroxychloroquine is used to treat malaria. Most of the companies manufacturing this drug are based in India. Last month, India lifted the ban on the drug at the request of US President Trump.

Comments

Popular posts from this blog

dry cough and burning eyes; Don't take allergies lightly, know how to avoid them

Some benefits of calcium in the body, if it decreases, what will be the harm? Know the details

Many foreign drug manufacturers may close down in India soon, this is the reason

Know the benefits of using Jethimadh in this problem including cold, cough in winter

Does sneezing really stop the heart beating? Know the facts

These 5 super fruits will help prevent blockage in the heart

Know the benefits of using Jethimadh in this problem including cold, cough in winter

In India, the infection rate of Kovid-12 is higher among the youth up to 18 years of age.

These 5 symptoms of diabetes are very common, unrecognized by people and increased sugar levels

Corona vaccine will be available by June 2021, assured by Hyderabad-based Bharat Biotech